TY - JOUR
T1 - Proceedings of the 28th Annual Congress of the International Liver Transplantation Society
AU - Shaji Mathew, Johns
AU - Shingina, Alexandra
AU - Khan, Mohammad Qasim
AU - Wilson, Elizabeth
AU - Syn, Nicholas
AU - Rammohan, Ashwin
AU - Alconchel, Felipe
AU - Hakeem, Abdul Rahman
AU - Shankar, Sadhana
AU - Patel, Dhupal
AU - Keskin, Onur
AU - Liu, Jiang
AU - Nasralla, David
AU - Mazzola, Alessandra
AU - Patel, Madhukar S.
AU - Tanaka, Tomohiro
AU - Victor, David
AU - Yoon, Uzung
AU - Yoon, Young In
AU - Vinaixa, Carmen
AU - Kirchner, Varvara
AU - De Martin, Eleonora
AU - Ghobrial, R. Mark
AU - Chadha, Ryan
N1 - Publisher Copyright:
© 2024 Lippincott Williams and Wilkins. All rights reserved.
PY - 2024/5
Y1 - 2024/5
N2 - The 2023 Joint International Congress of the International Liver Transplantation Society (ILTS), the European Liver and Intestine Transplant Association (ELITA), and the Liver Intensive Care Group of Europe (LICAGE) held in Rotterdam, the Netherlands, marked a significant recovery milestone for the liver transplant community after COVID-19. With 1159 participants and a surge in abstract submissions, the event focused on "Liver Disorders and Transplantation: Innovations and Evolving Indications." This conference report provides a comprehensive overview of the key themes discussed during the event, encompassing Hepatology, Anesthesia and Critical Care, Acute Liver Failure, Infectious Disease, Immunosuppression, Pediatric Liver Transplantation, Living Donor Liver Transplantation, Transplant Oncology, Surgical Approaches, and Machine Perfusion. The congress provided a platform for extensive discussions on a wide range of topics, reflecting the continuous advancements and collaborative efforts within the liver transplant community.
AB - The 2023 Joint International Congress of the International Liver Transplantation Society (ILTS), the European Liver and Intestine Transplant Association (ELITA), and the Liver Intensive Care Group of Europe (LICAGE) held in Rotterdam, the Netherlands, marked a significant recovery milestone for the liver transplant community after COVID-19. With 1159 participants and a surge in abstract submissions, the event focused on "Liver Disorders and Transplantation: Innovations and Evolving Indications." This conference report provides a comprehensive overview of the key themes discussed during the event, encompassing Hepatology, Anesthesia and Critical Care, Acute Liver Failure, Infectious Disease, Immunosuppression, Pediatric Liver Transplantation, Living Donor Liver Transplantation, Transplant Oncology, Surgical Approaches, and Machine Perfusion. The congress provided a platform for extensive discussions on a wide range of topics, reflecting the continuous advancements and collaborative efforts within the liver transplant community.
UR - http://www.scopus.com/inward/record.url?scp=85190745900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85190745900&partnerID=8YFLogxK
U2 - 10.1097/LVT.0000000000000330
DO - 10.1097/LVT.0000000000000330
M3 - Article
C2 - 38240602
AN - SCOPUS:85190745900
SN - 1527-6465
VL - 30
SP - 544
EP - 554
JO - Liver Transplantation
JF - Liver Transplantation
IS - 5
ER -